Community Group Presentation with James Berry, MD, MPH & Sarah Luppino, MSN, NP-BC

Date & Time
Tuesday, April 13, 2021 2:00-3:30 PM Eastern Time (US and Canada)
Location

MA

Register in advance for this meeting

Join us for a special Community Group Presentation!

Hot Topics in ALS: Feeding Tubes and COVID-19 Vaccines (Massachusetts Perspectives) with Dr. James Berry, MD, MPH and Sarah Luppino, MSN, NP-BC from the MGH ALS Clinic
 

Image
Healey ALS Center and Mass General Hospital Logos

 

The ALS Association Massachusetts Chapter is thrilled to have Dr. James Berry, MD, MPH and Sarah Luppino, MSN, NP-BC from the MGH ALS Clinic join us to discuss two hot topics in ALS clinical care that are frequently discussed in our Community Groups – COVID-19 vaccines and feeding tubes. Their talk will feature a 30-45 minute presentation followed by a 45-60 minute Q&A period.  

After registering, you will receive a confirmation email containing information about joining the meeting.

Meet Our Speakers

Image
James D Berry, MD, MPH Headshot
James D. Berry, MD, MPH 
Winthrop Family Scholar in ALS Sciences 
Chief, Division of ALS and Motor Neuron Diseases 
Associate Professor of Neurology, Harvard Medical School 

 Dr. Berry leads the Massachusetts General Hospital clinic at the Healey Center for ALS, caring for patients and helping to build and lead the multidisciplinary care team. He has helped to found the Telemedicine for People with ALS (TelePALS) program, the ALS House Call Program and the Parenting at a Challenging Time (PACT) programs within the clinic. 

Dr. Berry is also a dedicated ALS clinical researcher, with a focus on biomarker development and ALS clinical trials. He oversees a large biorepository, collecting, storing and sharing blood, DNA, and spinal fluid and accompanying patient information, which allows researchers around the globe to conduct critical research identifying biomarkers of ALS and developing novel therapeutics. He is particularly interested in changes in the immune system and their relationship with ALS onset and progression. 

Dr. Berry also leads projects developing digital endpoints for ALS trials that will help increase the objective data for trials while decreasing the burden on trial participants. Finally, he is deeply committed to developing novel therapeutics by translating discoveries in the lab into clinical trials and leading clinical trials that will transform our approach to care in ALS.  

Image
Sarah Luppino, MSN, NP-BC Headshot
Sarah Luppino, MSN, NP-BC
Associate Site Director
Healey & AMG Center for Research
Massachusetts General Hospital

In her role, Sarah provides leadership and supervision to guide research staff in the implementation of translational clinical trials. In addition, she cares for patients as a Nurse Practitioner in the Amyotrophic Lateral Sclerosis (ALS) clinic. Sarah is committed to the delivery of consistent, high quality research and patient care and to providing operational efficiencies and support to research staff in their efforts to conduct trials at the highest level for people with ALS.  

Sarah earned her Bachelor of Science from Boston College and both Nursing degree and her Master of Science in Nursing degree at the MGH Institute of Health Professions.

For more information, contact:

Email your vaccine and feeding tube questions by end of day, Friday April 9th to [email protected]